The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Brown Cbe, John Robert, Dr
    Non-Executive Director born in March 1955
    Individual (8 offsprings)
    Officer
    2019-07-29 ~ now
    OF - Director → CIF 0
  • 2
    Rees, Lyn Dafydd
    Company Director born in March 1973
    Individual (17 offsprings)
    Officer
    2018-07-03 ~ now
    OF - Director → CIF 0
  • 3
    Gibson, Steven Michael
    Accountant born in September 1982
    Individual (12 offsprings)
    Officer
    2023-09-08 ~ now
    OF - Director → CIF 0
  • 4
    York House, School Lane, Chandler's Ford, Eastleigh, England
    Active Corporate (3 parents, 5 offsprings)
    Person with significant control
    2024-01-15 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
Ceased 33
  • 1
    Roberts, Charles Edward Selkirk
    Company Director born in September 1977
    Individual (9 offsprings)
    Officer
    2014-07-04 ~ 2016-07-01
    OF - Director → CIF 0
  • 2
    Mason, Joanne Nicola, Dr
    Chief Scientific Officer born in May 1974
    Individual (2 offsprings)
    Officer
    2021-03-17 ~ 2023-01-11
    OF - Director → CIF 0
    2023-05-22 ~ 2023-09-08
    OF - Director → CIF 0
  • 3
    Slater, Christopher James
    Company Director born in December 1967
    Individual (10 offsprings)
    Officer
    2000-04-13 ~ 2003-09-01
    OF - Director → CIF 0
  • 4
    Rehm, George
    Director born in July 1948
    Individual
    Officer
    2006-10-30 ~ 2010-04-20
    OF - Director → CIF 0
  • 5
    Bond, Terence
    Company Director born in July 1938
    Individual (4 offsprings)
    Officer
    2000-04-13 ~ 2013-12-04
    OF - Director → CIF 0
  • 6
    Denman Iv, William Tocor, Dr
    Chief Medical Officer born in September 1961
    Individual (1 offspring)
    Officer
    2015-11-01 ~ 2018-05-14
    OF - Director → CIF 0
  • 7
    Tavener, Mary Geraldine
    Non-Executive Director born in January 1962
    Individual (1 offspring)
    Officer
    2022-01-25 ~ 2023-09-08
    OF - Director → CIF 0
  • 8
    Chang, Alan
    N/A born in March 1968
    Individual
    Officer
    2017-03-02 ~ 2018-07-03
    OF - Director → CIF 0
  • 9
    Jeffreys, Hayden William
    Commercial Director born in September 1975
    Individual (2 offsprings)
    Officer
    2018-10-02 ~ 2023-01-11
    OF - Director → CIF 0
  • 10
    Slater, James Derrick
    Financier born in March 1929
    Individual
    Officer
    2000-04-13 ~ 2000-07-16
    OF - Director → CIF 0
    2002-02-27 ~ 2006-10-30
    OF - Director → CIF 0
  • 11
    Chang, Bill
    N/A born in May 1975
    Individual
    Officer
    2017-03-02 ~ 2023-09-08
    OF - Director → CIF 0
  • 12
    Leeser, Andrew
    Chief Restructuring Officer born in April 1958
    Individual (11 offsprings)
    Officer
    2023-01-23 ~ 2023-09-08
    OF - Director → CIF 0
  • 13
    Browne, Harry Gray, Doctor
    Pathologist born in November 1929
    Individual
    Officer
    2000-06-13 ~ 2000-08-02
    OF - Director → CIF 0
  • 14
    Gulati, Sandeep, Dr
    Science Officer born in October 1963
    Individual
    Officer
    2006-10-31 ~ 2014-06-13
    OF - Director → CIF 0
  • 15
    Little, Stephen, Dr
    Helathcare born in January 1957
    Individual (3 offsprings)
    Officer
    2014-07-04 ~ 2023-01-11
    OF - Director → CIF 0
  • 16
    Broome, John Denis, Dr
    Pathologist born in August 1931
    Individual
    Officer
    2000-06-13 ~ 2006-09-11
    OF - Director → CIF 0
  • 17
    Dixey, Richard, Doctor
    Director born in August 1952
    Individual
    Officer
    2000-08-09 ~ 2006-10-26
    OF - Director → CIF 0
  • 18
    Kelly, Michael Woods
    Executive Officer born in March 1944
    Individual
    Officer
    2006-10-30 ~ 2009-06-12
    OF - Director → CIF 0
  • 19
    Hsu, Keng
    Company Director born in September 1977
    Individual
    Officer
    2018-07-03 ~ 2019-07-10
    OF - Director → CIF 0
  • 20
    Dean, Robert William
    Senior Vp born in January 1942
    Individual
    Officer
    2006-10-31 ~ 2014-03-21
    OF - Director → CIF 0
  • 21
    Evans, David Eric
    Company Director born in May 1960
    Individual (90 offsprings)
    Officer
    2014-07-04 ~ 2016-09-07
    OF - Director → CIF 0
  • 22
    Reynolds, Peter
    Company Director born in May 1938
    Individual (4 offsprings)
    Officer
    2007-07-13 ~ 2013-12-04
    OF - Director → CIF 0
  • 23
    Collins, Peter
    Healthcare born in December 1958
    Individual (4 offsprings)
    Officer
    2014-07-04 ~ 2018-11-01
    OF - Director → CIF 0
  • 24
    Hextall, Barry Kenneth
    Finance Director born in November 1967
    Individual (5 offsprings)
    Officer
    2015-06-04 ~ 2023-03-17
    OF - Director → CIF 0
    Hextall, Barry Kenneth
    Individual (5 offsprings)
    Officer
    2015-06-04 ~ 2023-09-29
    OF - Secretary → CIF 0
  • 25
    Mustoe, Nicholas
    Company Director born in July 1961
    Individual (8 offsprings)
    Officer
    2014-01-27 ~ 2022-01-25
    OF - Director → CIF 0
  • 26
    Tompkins, Henry John Mark
    Director born in November 1940
    Individual (1 offspring)
    Officer
    2001-12-19 ~ 2003-09-01
    OF - Director → CIF 0
  • 27
    Jones, Mark
    Individual (781 offsprings)
    Officer
    2000-04-13 ~ 2005-09-30
    OF - Secretary → CIF 0
  • 28
    Reynolds, Adam
    Company Director born in July 1962
    Individual (25 offsprings)
    Officer
    2013-12-04 ~ 2023-01-11
    OF - Director → CIF 0
  • 29
    Seaton, Jonathan Alexander
    Director born in November 1971
    Individual
    Officer
    2019-08-15 ~ 2023-09-08
    OF - Director → CIF 0
  • 30
    Viggars, Julian George
    Director born in January 1968
    Individual (46 offsprings)
    Officer
    2001-01-19 ~ 2006-10-30
    OF - Director → CIF 0
  • 31
    Collingbourne, Mark Kingsley
    Finance Director born in October 1965
    Individual (23 offsprings)
    Officer
    2014-01-27 ~ 2015-06-04
    OF - Director → CIF 0
    Collingbourne, Mark Kingsley
    Individual (23 offsprings)
    Officer
    2005-05-25 ~ 2015-06-04
    OF - Secretary → CIF 0
  • 32
    PLUS PLASTICS LIMITED - 1996-07-18
    30 Aldwick Avenue, Bognor Regis, Sussex
    Active Corporate (1 parent, 1 offspring)
    Equity (Company account)
    100 GBP2024-03-31
    Officer
    2000-04-13 ~ 2000-04-13
    PE - Secretary → CIF 0
  • 33
    COUNTRYSIDE (WALKING & CYCLING) HOLIDAYS LIMITED - 1996-07-18
    30 Aldwick Avenue, Bognor Regis, Sussex
    Active Corporate (1 parent)
    Equity (Company account)
    100 GBP2024-03-31
    Officer
    2000-04-13 ~ 2000-04-13
    PE - Director → CIF 0
parent relation
Company in focus

YOURGENE HEALTH LIMITED

Previous names
YOURGENE HEALTH PLC - 2023-09-27
PREMAITHA HEALTH PLC - 2018-11-02
VIALOGY PLC - 2014-07-03
ORIGINAL INVESTMENTS PLC - 2006-10-30
BIOPROJECTS INTERNATIONAL PLC - 2005-09-28
Standard Industrial Classification
64209 - Activities Of Other Holding Companies N.e.c.
Brief company account
Operating Profit/Loss
-26,733,576 GBP2023-04-01 ~ 2023-12-31
-12,359,683 GBP2022-04-01 ~ 2023-03-31
Other Interest Receivable/Similar Income (Finance Income)
1,042,867 GBP2023-04-01 ~ 2023-12-31
643,144 GBP2022-04-01 ~ 2023-03-31
Interest Payable/Similar Charges (Finance Costs)
-1,260,393 GBP2023-04-01 ~ 2023-12-31
-942,221 GBP2022-04-01 ~ 2023-03-31
Profit/Loss on Ordinary Activities Before Tax
-26,951,102 GBP2023-04-01 ~ 2023-12-31
-12,658,760 GBP2022-04-01 ~ 2023-03-31
Profit/Loss
-26,951,102 GBP2023-04-01 ~ 2023-12-31
-12,658,760 GBP2022-04-01 ~ 2023-03-31
Fixed Assets - Investments
11,312,281 GBP2023-03-31
Fixed Assets
9,072,257 GBP2023-12-31
22,217,379 GBP2023-03-31
Debtors
Current
736,894 GBP2023-12-31
6,882,859 GBP2023-03-31
Cash at bank and in hand
1,369,445 GBP2023-12-31
1,783,247 GBP2023-03-31
Current Assets
2,106,339 GBP2023-12-31
8,666,106 GBP2023-03-31
Creditors
Current
-13,658,513 GBP2023-12-31
-4,757,274 GBP2023-03-31
Net Current Assets/Liabilities
-11,552,174 GBP2023-12-31
3,908,832 GBP2023-03-31
Total Assets Less Current Liabilities
-2,479,917 GBP2023-12-31
26,126,211 GBP2023-03-31
Creditors
Non-current
-10,688,753 GBP2023-12-31
-12,497,008 GBP2023-03-31
Net Assets/Liabilities
-14,490,573 GBP2023-12-31
12,460,529 GBP2023-03-31
Equity
Called up share capital
35,138,436 GBP2023-12-31
35,121,929 GBP2023-03-31
Share premium
74,946,029 GBP2023-12-31
72,199,358 GBP2023-03-31
Retained earnings (accumulated losses)
-143,892,118 GBP2023-12-31
-116,941,016 GBP2023-03-31
Equity
-14,490,573 GBP2023-12-31
12,460,529 GBP2023-03-31
Profit/Loss
Retained earnings (accumulated losses)
-26,951,102 GBP2023-04-01 ~ 2023-12-31
-12,658,760 GBP2022-04-01 ~ 2023-03-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-26,951,102 GBP2023-04-01 ~ 2023-12-31
-12,658,760 GBP2022-04-01 ~ 2023-03-31
Comprehensive Income/Expense
-26,951,102 GBP2023-04-01 ~ 2023-12-31
-12,658,760 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Depreciation Expense
138,048 GBP2023-04-01 ~ 2023-12-31
174,284 GBP2022-04-01 ~ 2023-03-31
Wages/Salaries
700,783 GBP2023-04-01 ~ 2023-12-31
989,387 GBP2022-04-01 ~ 2023-03-31
Social Security Costs
73,888 GBP2023-04-01 ~ 2023-12-31
159,597 GBP2022-04-01 ~ 2023-03-31
Staff Costs/Employee Benefits Expense
853,970 GBP2023-04-01 ~ 2023-12-31
1,183,141 GBP2022-04-01 ~ 2023-03-31
Average number of employees in administration and support functions
42023-04-01 ~ 2023-12-31
92022-04-01 ~ 2023-03-31
Average Number of Employees
42023-04-01 ~ 2023-12-31
92022-04-01 ~ 2023-03-31
Director Remuneration
447,702 GBP2023-04-01 ~ 2023-12-31
969,068 GBP2022-04-01 ~ 2023-03-31
Audit Fees/Expenses
18,500 GBP2023-04-01 ~ 2023-12-31
169,000 GBP2022-04-01 ~ 2023-03-31
Tax Expense/Credit at Applicable Tax Rate
-6,737,776 GBP2023-04-01 ~ 2023-12-31
-2,405,164 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Land and buildings, Owned/Freehold
995,401 GBP2023-12-31
995,401 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Owned/Freehold
545,643 GBP2023-12-31
412,461 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings, Owned/Freehold
133,182 GBP2023-04-01 ~ 2023-12-31
Owned/Freehold
138,048 GBP2023-04-01 ~ 2023-12-31
Investments in Subsidiaries
Cost valuation
13,966,616 GBP2023-12-31
13,966,616 GBP2023-03-31
Prepayments
591,445 GBP2023-03-31
Total Borrowings
Current, Amounts falling due within one year
2,140,502 GBP2023-03-31
Creditors
Current, Amounts falling due within one year
13,658,513 GBP2023-12-31
4,757,274 GBP2023-03-31
Total Borrowings
Non-current, Amounts falling due after one year
1,000,000 GBP2023-03-31
Creditors
Non-current, Amounts falling due after one year
10,688,753 GBP2023-12-31
12,497,008 GBP2023-03-31
Bank Borrowings
Non-current
1,000,000 GBP2023-03-31
Current
2,140,502 GBP2023-03-31
Par Value of Share
Class 1 ordinary share
0.002023-04-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
3,193,466,515 shares2023-12-31
3,176,959,792 shares2023-03-31
Par Value of Share
Class 2 ordinary share
0.012023-04-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
1,039,640,244 shares2023-12-31
1,039,640,244 shares2023-03-31
Par Value of Share
Class 3 ordinary share
0.102023-04-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
228,163,709 shares2023-12-31
228,163,709 shares2023-03-31
Number of Shares Issued (Fully Paid)
4,461,270,468 shares2023-12-31
4,444,763,745 shares2023-03-31
Nominal value of allotted share capital
35,138,436 GBP2023-04-01 ~ 2023-12-31
35,121,929 GBP2022-04-01 ~ 2023-03-31
Related profiles found in government register
  • YOURGENE HEALTH LIMITED
    Info
    YOURGENE HEALTH PLC - 2023-09-27
    PREMAITHA HEALTH PLC - 2018-11-02
    VIALOGY PLC - 2014-07-03
    ORIGINAL INVESTMENTS PLC - 2006-10-30
    BIOPROJECTS INTERNATIONAL PLC - 2005-09-28
    Registered number 03971582
    Skelton House Lloyd Street North, Manchester Science Park, Manchester M15 6SH
    Private Limited Company incorporated on 2000-04-13 (25 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-21
    CIF 0
  • YOURGENE HEALTH LIMITED
    S
    Registered number 03971582
    Skelton House, Lloyd Street North, Manchester Science Park, Manchester, England, M15 6SH
    Limited Company in Companies House, Uk, England & Wales
    CIF 1
    Limited Company in Register Of Companies, United Kingdom
    CIF 2
    Private Limited Company in Companies House, England
    CIF 3
(more)
child relation
Offspring entities and appointments
Active 4
  • 1
    Skelton House Lloyd Street North, Manchester Science Park, Manchester, United Kingdom
    Dissolved Corporate (3 parents)
    Person with significant control
    2019-04-25 ~ dissolved
    CIF 4 - Ownership of shares – 75% or more → OE
    CIF 4 - Ownership of voting rights - 75% or more → OE
  • 2
    YOURGENE HEALTH UK LIMITED - 2019-12-06
    YOURGENE HEALTH LIMITED - 2018-11-02
    Skelton House Lloyd Street North, Manchester Science Park, Manchester, England
    Dissolved Corporate (2 parents)
    Equity (Company account)
    1 GBP2020-04-30
    Person with significant control
    2024-04-15 ~ dissolved
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
  • 3
    EX5 GENOMICS (UK) LTD - 2022-04-21
    Skelton House Lloyd Street North, Manchester Science Park, Manchester, England
    Active Corporate (4 parents)
    Equity (Company account)
    187,075 GBP2022-03-31
    Person with significant control
    2020-07-03 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
  • 4
    PREMAITHA LIMITED - 2019-12-11
    PREMAITHA HEALTH LTD - 2014-07-03
    Skelton House Lloyd Street North, Manchester Science Park, Manchester, England
    Active Corporate (4 parents)
    Person with significant control
    2016-04-06 ~ now
    CIF 3 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.